Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-Depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies.

Next Previous
X
Search
Trial Profile

A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-Depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalotimagene-carmaleucel (Primary)
  • Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Lymphoma; Multiple myeloma; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use
  • Sponsors AGC Biologics

    • Most Recent Events

    • 06 Dec 2016 Pooled results from this and other phase III study (profile 700030106) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
    • 05 Dec 2016 Results published in the MolMed Media Release.
    • 05 Dec 2016 According to a MolMed media release, data from this trial is summarised during a symposium at the 1st EBMT International Transplant Course.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top